Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) Other Operating Expenses (2016 - 2025)

Avanos Medical (AVNS) has disclosed Other Operating Expenses for 13 consecutive years, with $1.4 million as the latest value for Q4 2025.

  • Quarterly Other Operating Expenses fell 75.0% to $1.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $400000.0 through Dec 2025, down 89.74% year-over-year, with the annual reading at $400000.0 for FY2025, 89.74% down from the prior year.
  • Other Operating Expenses hit $1.4 million in Q4 2025 for Avanos Medical, up from -$2.3 million in the prior quarter.
  • In the past five years, Other Operating Expenses ranged from a high of $11.4 million in Q4 2021 to a low of -$22.0 million in Q1 2021.
  • Historically, Other Operating Expenses has averaged -$1.7 million across 5 years, with a median of -$550000.0 in 2022.
  • Biggest five-year swings in Other Operating Expenses: crashed 2100.0% in 2021 and later skyrocketed 900.0% in 2025.
  • Year by year, Other Operating Expenses stood at $11.4 million in 2021, then tumbled by 103.51% to -$400000.0 in 2022, then tumbled by 525.0% to -$2.5 million in 2023, then surged by 324.0% to $5.6 million in 2024, then plummeted by 75.0% to $1.4 million in 2025.
  • Business Quant data shows Other Operating Expenses for AVNS at $1.4 million in Q4 2025, -$2.3 million in Q3 2025, and -$300000.0 in Q2 2025.